Document is current
Any future updates will be listed below
-
Authors
Guillem, Lluïsa https://orcid.org/0000-0001-7814-1303
Alia-Ramos, Pedro https://orcid.org/0000-0001-9662-6283
Gonzalez-Diaz, Aida https://orcid.org/0000-0002-8326-1307
Ardanuy, Carmen https://orcid.org/0000-0003-0225-607X
Boix-Palop, Lucia https://orcid.org/0000-0002-4080-0008
Van den Eynde, Eva https://orcid.org/0000-0001-8512-0009
Cabellos, Carmen https://orcid.org/0000-0001-7392-7382
-
Funding
Funding for this research was provided by:
Insituto de Salud Carlos III (PI18/00814)
- License Information
-
More Information
Article History
Received: 3 December 2024
Accepted: 23 April 2025
First Online: 6 May 2025
Declarations
:
: C.A. has been a scientific adviser for, and/or has received research funding from, Merck Sharp & Dohme Corp and Pfizer.The rest of the autors declare they have no conflicts of interest.
